Pranlukast Impurity 4 | CAS 157101-44-5 - Request Quote
Pranlukast Impurity 4
| SZ CAT No: | SZ-P101008 |
| CAS No | 157101-44-5 |
| Mol.F. | C27H25N5O5 |
| Mol.Wt. | 499.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pranlukast Impurity 4 is chemically N-(2-hydroxy-3-(3-oxo-3-(1H-tetrazol-5-yl)propanoyl)phenyl)-4-(4-phenylbutoxy)benzamide. Pranlukast Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Pranlukast Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pranlukast.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 157101-44-5
Purchase 157101-44-5
Order 157101-44-5
Enquire 157101-44-5
price of 157101-44-5
157101-44-5 Supplier
157101-44-5 Manufacturer
157101-44-5 Exporter
buy high quality Pranlukast Impurity 4
Purchase Pranlukast Impurity 4
Pranlukast Impurity 4 suppliers
Pranlukast Impurity 4 manufacturers
Pranlukast Impurity 4 price
Order Pranlukast Impurity 4
Enquire Pranlukast Impurity 4
Pranlukast Impurity 4 cost
Pranlukast Impurity 4 Supplier
Pranlukast Impurity 4 Distributor
Pranlukast Impurity 4 for Method Validation
Pranlukast Reference Standard
Pranlukast Impurity 4 for ANDA Filing
Pranlukast Impurity 4 for Forced Degradation Studies
Pranlukast Impurity 4 Identification Standards
Pranlukast Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


